Physicians for Reproductive Health: Homepage
Donate
  • About Us
    • Mission and History
    • Our Impact
    • PRH in the News
    • Financials
    • Our People
  • Our Focus
    • Abortion
    • Contraception
    • Access to Care
  • Provider Resources
    • Advocacy Training
    • Medical Education
    • Direct Physician Support
  • Take Action
    • Make a Difference
    • Attend an Event
    • Wear Your Support
    • Donate for Change
  • PRH in Action
    • PRH In Action
  • Accessibility
Donate

Tagged: FDA

Press Release
January 3, 2023

FDA Affirms Mifepristone is Safe and Should Be Accessible

Today the FDA updated its guidance on mifepristone to no longer require in-person dispensing. President and CEO of Physicians for Reproductive Health Dr. Jamila Perritt, […]

  • FDA (3)
  • medication abortion (25)
  • mifepristone (3)
  • press release (224)
Press Release
April 13, 2021

FDA Lifts Restrictions on Medication Abortion

Late last night, the Food and Drug Administration shared by way of a letter to advocates at the American College of Obstetricians and Gynecologists that […]

  • abortion (511)
  • FDA (3)
  • medication abortion (25)
Update
March 10, 2021

PRH in Action

Medication Abortion – It’s Time to Act! Welcome back to our blog series, PRH in Action! This month we’re diving into the unnecessary regulation of medication abortion care and what the […]

  • Biden (6)
  • FDA (3)
  • medication abortion (25)
  • mifepristone (3)
  • PRH in Action (21)

Sitemap

  • Newsroom
  • Careers
  • Privacy Policy
  • Contact Us

Join us

We deliver breaking news and ways to take action straight to your inbox.

Subscribe

Social Media

  • Facebook
  • Instagram
  • Twitter